Stay updated on ALX-0171 Phase I Healthy Male Volunteers Clinical Trial
Sign up to get notified when there's something new on the ALX-0171 Phase I Healthy Male Volunteers Clinical Trial page.

Latest updates to the ALX-0171 Phase I Healthy Male Volunteers Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedThe page footer now displays Revision: v3.3.3 and no longer includes HHS Vulnerability Disclosure or Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedThe page shows a new revision label v3.3.2 being added and v3.2.0 removed, with no changes to study content or details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check48 days agoChange DetectedThe page no longer displays the government funding/operating-status notice. This does not affect the study details, eligibility criteria, or trial results listed on the page.SummaryDifference0.5%

- Check63 days agoChange DetectedThe updates appear to be layout and styling changes to the Study Details page, with no alteration to core data such as the study title, eligibility criteria, or primary outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check91 days agoChange Detected- Added a government-operating-status notice and a link to cc.nih.gov, clarifying that some transactions may be affected by funding. - Updated the version from v3.1.0 to v3.2.0.SummaryDifference6%

- Check98 days agoChange DetectedAdds version v3.1.0 and removes several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) plus an older version tag (v3.0.2).SummaryDifference0.8%

Stay in the know with updates to ALX-0171 Phase I Healthy Male Volunteers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALX-0171 Phase I Healthy Male Volunteers Clinical Trial page.